In vivo experiments revealed that the 125I + miR-615 antagomir-treated mice had decreased miR-615 expression, enhanced tumor growth and Ki67 expression, and reduced apoptosis of CRC cells. The gene discussed is MKI67; the disease is colorectal carcinoma.